Company Overview

Decibel Cannabis Company Inc. is a Canadian cannabis producer focused on premium recreational cannabis products, with operations spanning cultivation, processing, manufacturing, and branded product distribution. The company operates within the legal cannabis industry in Canada and is listed on the TSX Venture Exchange under the ticker DB. Decibel’s primary revenue drivers come from branded dried flower, pre-rolls, concentrates, and infused cannabis products sold through provincial distribution systems and licensed retail channels. Its portfolio includes well-known brands such as Qwest, General Admission, and Vox, which target both premium and value-oriented consumer segments.

The company evolved through a combination of cultivation asset development and brand-focused acquisitions. Decibel expanded its market position through the acquisition of AgMedica Bioscience Inc., which strengthened its extraction and processing capabilities, and through investments in high-efficiency cultivation infrastructure. The company has positioned itself as a consumer-brand-driven cannabis operator with an emphasis on product quality, high-potency extracts, and operational efficiency. Public filings and investor materials consistently describe its strategy as focused on premium branding, scale efficiencies, and category leadership in cannabis concentrates and infused products.

Business Operations

Decibel generates revenue primarily through the production and sale of cannabis products across Canada’s regulated adult-use market. Its operations include cultivation at facilities in Alberta, product manufacturing and extraction, and national distribution through provincial cannabis boards. The company’s major business activities include branded cannabis product development, extraction and vape manufacturing, pre-roll production, and dried flower sales. Key operational assets include the Thunderchild cultivation facility, extraction and processing infrastructure inherited through AgMedica Bioscience Inc., and automated manufacturing capabilities that support high-volume vape and infused product production.

The company operates primarily in Canada but distributes products nationally across multiple provinces including Ontario, Alberta, British Columbia, and Quebec. Decibel has emphasized vertically integrated operations, allowing greater control over cultivation quality, extraction, manufacturing, and branding. Strategic relationships with provincial wholesalers and retail networks are central to revenue generation. Public disclosures indicate that vape products and infused pre-rolls have become increasingly important contributors to sales growth, particularly under the General Admission brand, which has ranked competitively in Canadian recreational cannabis categories according to industry retail tracking data.

Strategic Position & Investments

Decibel’s strategic direction has centered on strengthening branded cannabis product leadership while improving operational margins and cash flow generation. The company has invested in automation, extraction technologies, and high-efficiency cultivation systems to reduce production costs and improve product consistency. Management has consistently highlighted premiumization and category expansion as core priorities, particularly in cannabis concentrates, infused pre-rolls, and vaporizer products. Its acquisition of AgMedica Bioscience Inc. materially expanded extraction capabilities and provided additional processing scale, supporting the company’s transition toward higher-margin derivative products.

The company has also focused on optimizing its product portfolio around scalable consumer brands. General Admission has become a major growth platform in vape cartridges and infused products, while Qwest remains associated with premium flower offerings. Decibel has pursued selective capital investments rather than broad international expansion, prioritizing profitability and market share within Canada’s recreational cannabis sector. Public filings and earnings materials indicate ongoing attention to debt management, operational discipline, and maintaining competitiveness in a highly price-sensitive Canadian market.

Geographic Footprint

Decibel Cannabis Company Inc. is headquartered in Calgary, Alberta, with operational facilities primarily located in Alberta and Ontario. The company’s products are distributed throughout Canada via provincial cannabis distribution systems and licensed retail channels. Its strongest market presence has historically been in major Canadian recreational markets including Ontario, Alberta, and British Columbia, where branded products have achieved meaningful retail penetration.

Although Decibel’s core business remains concentrated in Canada, the company has previously referenced international opportunities through medical cannabis channels and strategic partnerships. However, publicly verifiable revenue exposure outside Canada appears limited based on available filings. Its operational influence is therefore primarily domestic, with nationwide Canadian distribution serving as the company’s principal geographic footprint.

Leadership & Governance

Decibel’s leadership team has emphasized operational efficiency, disciplined capital allocation, and consumer-focused brand development within the competitive Canadian cannabis industry. Corporate governance and strategic direction are disclosed through public company filings, management discussion and analysis documents, and investor presentations. Leadership communications have consistently focused on achieving sustainable profitability, strengthening brand equity, and maintaining disciplined production economics in a challenging regulatory environment.

Key executives include:

• Benjamin Sze – Chief Executive Officer
• Benjamin Sze – Interim Chief Financial Officer (during certain reporting periods, based on company disclosures)
• Paul Wilson – Founder and former Chief Executive Officer
• Cameron Brown – Chief Operating Officer
• Myles McGovern – Senior executive leadership roles associated with operations and commercialization during prior reporting periods

Public disclosures indicate that the company’s governance approach prioritizes operational execution, cost control, and category leadership in cannabis derivative products. Some executive role changes have occurred over time, and certain historical titles may vary across reporting periods. Data inconclusive based on available public sources regarding the most current composition of all senior leadership positions beyond publicly disclosed filings.